4745-55-5

Basic information

• Product Name: Vitacamphor
• Synonyms: 7-Norbornanecarboxaldehyde, 1,7-dimethyl-2-oxo-, trans-(+)- (8CI);Bicyclo[2.2.1]heptane-7-carboxaldehyde, 1,7-dimethyl-2-oxo-, (1R,4R,7R)- (9CI);Bicyclo[2.2.1]heptane-7-carboxaldehyde, 1,7-dimethyl-2-oxo-, anti-(+)-;trans-pi-oxocamphor;Vitacampher;Vitacamphor;trans-π-Oxocamphor
• CAS NO: 4745-55-5
• Molecular Formula: C₁₀H₁₄O₂
• Molecular Weight: 166.22
• Mol File: 4745-55-5.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 244.4°C at 760 mmHg
• Flash Point: 89.6°C
• Appearance: /
• Density: 1.175g/cm³
• Vapor Pressure: 0.0305mmHg at 25°C
• Refractive Index: 1.568
• CAS DataBase Reference: Vitacamphor(CAS DataBase Reference)
• NIST Chemistry Reference: Vitacamphor(4745-55-5)
• EPA Substance Registry System: Vitacamphor(4745-55-5)

Safety Data

• Hazardous Substances Data: 4745-55-5(Hazardous Substances Data)

Usage

InChI:InChI=1/C10H14O2/c1-9-4-3-7(5-8(9)12)10(9,2)6-11/h6-7H,3-5H2,1-2H3

Upstream product

• 54793-88-3 (1R)-2-oxo-bornanoic acid-⁽⁸⁾-chloride 
• 10293-10-4 3-endo-9-dibromo-1,7,7-trimethylbicyclo<2.2.1>heptan-2-one 
• 10334-06-2 9-hydroxy-1,7,7-trimethylbicyclo<2.2.1>heptan-2-one 

Downstream Products

• 64-18-6 formic acid 
• 10334-07-3 (1R)-trans-Isoketopinic acid 

Relevant articles and documents

Synthetic process for oxycamphor

The invention discloses a synthetic process for oxycamphor. The synthetic process comprises the following steps: subjecting (+)-3,9-dibromocamphor and ethyl acetate to ester formation under the catalysis of 1,8-diazabicyclo[5.4.0]undec-7-ene, then carrying out reduction to obtain 9-acetoxycamphor, adding sodium hydroxide and N, N-dimethylformamide, carrying out a hydrolysis reaction to obtain (+)-9-hydroxycamphor, reducing 9-hydroxycamphor with lithium aluminum hydride in a tetrahydrofuran solution to obtain oxycamphor, performing concentration, and carrying out dissolving and decolorizing with dichloromethane to obtain the target oxycamphor. The method is high in yield and friendly to environment, and the purity of the obtained target oxycamphor is larger than 99.5%, which reaches currentnational injection standards in China.